Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
2.
3.

The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.

Ghiasi H, Cai S, Slanina SM, Perng GC, Nesburn AB, Wechsler SL.

J Infect Dis. 1999 May;179(5):1086-93.

PMID:
10191208
4.
5.

Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.

Ghiasi H, Perng GC, Nesburn AB, Wechsler SL.

Virus Res. 2000 Jul;68(2):137-44.

PMID:
10958985
8.

Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice.

Mott K, Brick DJ, van Rooijen N, Ghiasi H.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5605-15.

PMID:
18055810
9.

MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1.

Ghiasi H, Cai S, Nesburn AB, Wechsler SL.

Curr Eye Res. 1997 Nov;16(11):1152-8.

PMID:
9395776
10.
11.

Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.

Osorio Y, Cohen J, Ghiasi H.

Invest Ophthalmol Vis Sci. 2004 Feb;45(2):506-14.

PMID:
14744892
12.
14.

Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Matundan H, Mott KR, Ghiasi H.

J Virol. 2014 Jul;88(14):8016-27. doi: 10.1128/JVI.00913-14. Epub 2014 May 7.

15.

Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.

Osorio Y, Cai S, Hofman FM, Brown DJ, Ghiasi H.

Curr Eye Res. 2004 Aug-Sep;29(2-3):145-51.

PMID:
15512961
16.

Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Davido DJ, Tu EM, Wang H, Korom M, Gazquez Casals A, Reddy PJ, Mostafa HH, Combs B, Haenchen SD, Morrison LA.

J Virol. 2018 Aug 16;92(17). pii: e01036-18. doi: 10.1128/JVI.01036-18. Print 2018 Sep 1.

PMID:
29950407
17.
18.

Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines.

Ghiasi H, Hofman FM, Wallner K, Cai S, Perng G, Nesburn AB, Wechsler SL.

Vaccine. 2000 Dec 8;19(9-10):1266-73.

PMID:
11137266
20.

A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.

Royer DJ, Gurung HR, Jinkins JK, Geltz JJ, Wu JL, Halford WP, Carr DJJ.

J Virol. 2016 May 12;90(11):5514-5529. doi: 10.1128/JVI.00517-16. Print 2016 Jun 1.

Supplemental Content

Support Center